In summary, we found that the activation of NLRP3 inflammasome participated in the development and progression of AA-induced nephropathy and IL-22 exerted a nephroprotective effect by suppressing renal NLRP3 inflammasome activation. The gene discussed is NLRP3; the disease is kidney disorder.